Therefore, it seems that inhibiting NRP-1 using polymeric nanoparticles to deliver specific siRNAs inhibits tumor growth or reduces proliferation, making it a promising approach for treating of PDAC [35]. The gene discussed is NRP1; the disease is neoplasm.